Loading clinical trials...

COMPLETEDPhase 3NCT02114151

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

The purpose of the study is to investigate the efficacy and safety of 12 weeks of simeprevir (150 mg qd) in combination with sofosbuvir (400 mg qd) in chronic hepatitis C virus (HCV) genotype 1 infect...

Lead sponsor: Janssen Infectious Diseases BVBA•32 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development

NCT06718530 · Hepatitis C Virus Infection

RECRUITING

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

NCT05361603 · Hepatitis C, Transmission, Intravenous Drug Abuser, and more

COMPLETED

Relinking Diagnosed But Untreated HCV Patients Back Into Care.

NCT05975216 · Hepatitis C Virus Infection

Not Yet Recruiting

Screening, Treatment, and Eradication of Hep C

NCT05071261 · Hepatitis C Virus Infection

UNKNOWN

Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)

NCT05906459 · Hepatitis C Virus Infection

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 4, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment103

Start dateApr 2014

Last updatedApr 4, 2016

Condition

Hepatitis C Virus Infection

Locations shown

Dothan, Alabama

Bakersfield, California

Chula Vista, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 4, 2016Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions